This section focuses on different types of vascular tumors, specifically hemangioma, angiosarcoma, and Kaposi's sarcoma.
Hemangioma
Definition: A benign tumor made up of blood vessels.
Common Features:
Often present at birth.
Frequently regresses during childhood, especially in children, reducing the need for surgical removal.
Important to monitor, especially when located on the face, to avoid unnecessary scarring.
Common Locations:
Primarily involves the skin.
Can also appear in the liver.
Identification:
Looks like a collection of blood in tissue.
Distinguishing from Purpura:
Pressing a hemangioma will cause blanching (due to blood being within the vessels).
A bruise (purpura) will not blanch as the blood is not contained within blood vessels.
Angiosarcoma
Definition: A malignant proliferation of endothelial cells lining blood vessels, indicating a sarcoma.
Characteristics:
Highly aggressive tumor.
Can affect various sites: skin, breast, liver.
Risk Factors:
Liver angiosarcoma is notably associated with exposure to:
Polyvinyl chloride (PVC).
Arsenic.
Thorotrast.
Kaposi's Sarcoma
Definition: A low-grade malignant tumor of endothelial cells, closely associated with Human Herpesvirus 8 (HHV-8).
Presentation:
Manifests as purple patches, plaques, or nodules on the skin.
Appearance due to proliferation of endothelial cells.
Distinguishing Features:
Pressing on the lesions does not result in blanching, as cells are not in actual vessels but rather interspersed with endothelial cells.
Affected Populations:
Eastern European males: Generally older male patients with localized skin lesions treated often by surgical removal.
AIDS patients: HHV-8 infection leads to tumors, can spread rapidly. Treatment may involve antiretroviral therapy to restore immune function and eliminate infected cells.
Transplant patients: Typically experience skin lesions that can spread. Treatment focuses on reducing immunosuppressive therapy to reinvigorate the immune response against infected cells.
Summary of Key Points:
Kaposi's sarcoma results from HHV-8 infection of endothelial cells, can lead to purple plaques, and has specific treatment considerations based on the patient population.